BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Policy

  Dr. Reddy’s Laboratories Announces the Launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market

  Dr. Reddy’s Laboratories Ltd. announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic equivalent generic version of Tecfidera® Delayed-Release Capsules, approved by the U.S. Food and Drug Administration.

  September 26, 2020

   · 

  3 min read
• Policy

  Statement from the Chief Public Health Officer of Canada on September 26, 2020

  In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

  September 26, 2020

   · 

  2 min read